Report

Australia regenerative medicine market is projected to grow at a significant CAGR during the forecast period, 2023-2027. The market growth can be attributed to the expanding healthcare infrastrcuture and increasing evolution in the pharmaceutical sector to design advanced drugs. Besides, increasing research & development activities to advance pharmaceutical products and find curative therapies for unknown diseases are contributing to the growth of Australia regenerative medicine market.
Regenerative medicines aid the replacement, engineering, or regeneration of human or animal cells. The drugs aid in the restoration of normal cell function. Regenerative medicines stimulate the body's repair system to heal irreparable tissues and organs to restore functions. Regenerative medicine has the potential to be used for the artificial generation of tissues and organs in the laboratory, which can then be safely implanted if the body is unable to heal under certain conditions. Cell therapy, immunomodulation therapy, and tissue engineering are examples of biomedical techniques and clinical therapies used in regenerative medicine.

Regenerative medicines are advanced pharmaceuticals undergoing continuous research and product development to provide better healthcare and patient care services. Biomedical methods such as cell therapy, immunomodulation therapy, and tissue engineering are becoming more common as medicine advances, fueling the growth of the Australia regenerative medicine market over the next five years.
Furthermore, increased investment in these biomedical procedures and research will help the Australia regenerative medicine market grow over the next five years. Australia Department of Industry, Innovation, and Science has provided a USD60 million grant through the CTM CRC to develop integrated, cost-effective, and accessible cell therapies that have further revolutionized regenerative medicine.
The rise in chronic neurological diseases and cancers that necessitate advanced medical treatment is anticipated fuel the growth of the Australia regenerative medicine market over the next five years. Regenerative medicine is being used to treat Alzheimer's disease, Parkinson's disease, cardiovascular disorders (CVDs), osteoporosis, and spinal cord injuries, fueling the market growth. Furthermore, the country's growing geriatric population, which is prone to diseases such as musculoskeletal, oncological, dermatological, and cardiological disorders, is aiding Australia's regenerative medicine market's growth over the next five years.
The Australia regenerative medicine market is segmented by type, application, end user, competitional landscape, and regional distribution. Based on type, the market is further divided into cell therapy, gene modification, tissue engineering, and others. The cell therapy segment is anticipated to hold the largest share in the Australia regenerative medicine market, owing to rising demand and dependability over cell therapy in the biomedical processes.
Key players operating in the Australia regenerative medicine market are Cell Therapies Pty Ltd., Hudson Institute, Orthocell Ltd., Q-Gen Cell Therapeutics, Westmead Viral Vector Facility, Sydney Cell & Gene Therapies, Auspep Holdings Ltd., Luina Bio Pty Ltd., among others.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023-2027
Objective of the Study:
- To analyze the historical growth in the size of the Australia regenerative medicine market from 2017 to 2021.
- To estimate and forecast the market size of Australia regenerative medicine market from 2023 to 2027 and growth rate until 2027.
- To classify and forecast the Australia regenerative medicine market based on type, application, end user, region, and company.
- To identify the dominant region or segment in the Australia regenerative medicine market.
- To identify drivers and challenges for the Australia regenerative medicine market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Australia regenerative medicine market.
- To identify and analyze the profiles of leading players operating in the Australia regenerative medicine market.
- To identify key sustainable strategies adopted by market players in Australia regenerative medicine market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the country.
TechSci Research calculated the market size of the Australia regenerative medicine market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as product manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, Australia regenerative medicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Australia Regenerative Medicine Market, By Type:
o Cell Therapy
o Gene Modification
o Tissue Engineering
o Others
- Australia Regenerative Medicine Market, By Application:
o Bone Graft Substitutes
o Osteoarticular Diseases
o Dermatology
o Cardiovascular Diseases
o Others
- Australia Regenerative Medicine Market, By End User:
o Academic
o Commercial
- Australia Regenerative Medicine Market, By Region:
o Northern Territory Region
o New South Wales Region
o Victoria Region
o Western Australia Region
o Queensland Region
o Tasmania Region
o South Australia Region
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Australia regenerative medicine market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).